Biotech ETFs Hold Their Breath

After plunging from the late February high and crossing below its short-term trend line, an exchange traded fund that tracks the widely monitored NASDAQ Biotech Index is now testing a technical breaking point that is keeping many investors on their toes. Stephen Suttmeier, chief technician at Bank...